PTD-DBM

PTD-DBM is a synthetic cell-penetrating research peptide engineered to interfere with the protein-protein interaction between CXXC5 and Dishevelled. This interaction normally functions as a negative-feedback brake on the Wnt/β-catenin signaling cascade. Investigators use PTD-DBM in controlled laboratory systems to examine how releasing that brake influences regenerative pathway activity. The compound is supplied strictly for in-vitro and experimental research applications.

PTD-DBM disrupts the binding interface between CXXC5 and Dishevelled, thereby relieving a key inhibitory constraint on Wnt/β-catenin signal transduction. Free Dishevelled can then more readily participate in the stabilization of β-catenin and subsequent nuclear signaling events. In experimental models this leads to measurable changes in pathway-responsive gene expression. The peptide’s cell-penetrating domain enables intracellular access without requiring additional delivery vehicles in most assay formats.

Laboratory studies of PTD-DBM center on hair-follicle neogenesis models, where Wnt/β-catenin activity is known to govern follicle development and cycling. Parallel work examines its effects in dermal wound-healing assays that track regenerative cellular responses. Researchers frequently co-apply PTD-DBM with valproic acid, another documented Wnt-pathway modulator, to explore combined pathway activation in these systems. All such investigations remain confined to in-vitro and non-clinical model platforms.

Published experimental work has shown that PTD-DBM elevates markers of Wnt/β-catenin pathway engagement in cultured dermal cells and tissue explants. In hair-follicle organoid and dermal-papilla models the peptide has been linked to increased expression of genes associated with regenerative programs. Co-treatment with valproic acid often amplifies these molecular readouts relative to either agent alone. Observed outcomes are restricted to laboratory model systems and do not extend beyond research contexts.

PTD-DBM is intended solely for in-vitro and laboratory research use. Standard peptide storage and reconstitution practices should be followed to preserve structural integrity and activity. Investigators prepare working solutions under sterile conditions appropriate for cell-culture or biochemical assays. The material is not formulated or approved for any form of administration outside controlled experimental protocols.